Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/30331
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2023-01-09T08:09:30Z-
dc.date.available2023-01-09T08:09:30Z-
dc.date.issued2020-06-
dc.identifier.citationYüksel, A. vd. (2020). "Unclear issues regarding Covid-19". Eurasian Journal of Medicine, 52(2), 191-196.tr_TR
dc.identifier.issn1308-8742-
dc.identifier.urihttps://doi.org/10.5152/eurasianjmed.2020.20092-
dc.identifier.urihttps://www.eajm.org/en/unclear-issues-regarding-covid-19-133288-
dc.identifier.urihttp://hdl.handle.net/11452/30331-
dc.description.abstractScientists from all over the world have been intensively working to discover different aspects of Coronavirus disease 2019 (COVID-19) since the first cluster of cases was reported in China. Herein, we aimed to investigate unclear issues related to transmission and pathogenesis of disease as well as accuracy of diagnostic tests and treatment modalities. A literature search on PubMed, Ovid, and EMBASE databases was conducted, and articles pertinent to identified search terms were extracted. A snow-ball search strategy was followed in order to retrieve additional relevant articles. It was reported that viral spread may occur during the asymptomatic phase of infection, and viral load was suggested to be a useful marker to assess disease severity. In contrast to immune response against viral infections, cytotoxic T lymphocytes decline in SARS-CoV-2 infection, which can be partially explained by direct invasion of T lymphocytes or apoptosis activated by SARS-CoV-2. Dysregulation of the urokinase pathway, cleavage of the SARS-CoV-2 Spike protein by FXa and FIIa, and consumption coagulopathy were the proposed mechanisms of the coagulation dysfunction in COVID-19. False-negative rates of reverse transcriptase polymerase chain reaction varied between 3% and 41% across studies. The probability of the positive test was proposed to decrease with the number of days past from symptom onset. Safety issues related to infection spread limit the use of high flow nasal oxygen (HFNO) and continuous positive airway pressure (CPAP) in hypoxic patients. Further studies are required to elucidate the challenging issues, thus enhancing the management of COVID-19 patients.en_US
dc.description.sponsorshipTurkish Thoracic Societyen_US
dc.language.isoenen_US
dc.publisherAvestr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectGeneral & internal medicineen_US
dc.subjectCoronavirusen_US
dc.subjectPathogenesisen_US
dc.subjectTransmissionen_US
dc.subjectVenous thromboembolismen_US
dc.subjectCoronavirusen_US
dc.subjectSepsisen_US
dc.subjectWuhanen_US
dc.titleUnclear issues regarding Covid-19en_US
dc.typeArticleen_US
dc.identifier.wos000542299000018tr_TR
dc.identifier.scopus2-s2.0-85087118043tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Göğüs Hastalıkları Anabilim Dalı.tr_TR
dc.identifier.startpage191tr_TR
dc.identifier.endpage196tr_TR
dc.identifier.volume52tr_TR
dc.identifier.issue2tr_TR
dc.relation.journalEurasian Journal of Medicineen_US
dc.contributor.buuauthorGünaydın, Fatma Esra-
dc.contributor.researcheridDWB-4345-2022tr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.collaborationYurt içitr_TR
dc.indexed.trdizinTrDizintr_TR
dc.identifier.pubmed32612430tr_TR
dc.subject.wosMedicine, general & internalen_US
dc.indexed.wosESCIen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.contributor.scopusid57210113218tr_TR
dc.subject.scopusCOVID-19 Coagulopathy; Thrombocytopenia; Patientsen_US
Appears in Collections:PubMed
Scopus
TrDizin
Web of Science

Files in This Item:
File Description SizeFormat 
Günaydın_vd_2020.pdf197.37 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons